Futura Medical plc (AIM:FUM)
London · Delayed Price · Currency is GBP · Price in GBX 0.5500
0.00 (0.00%)
Jun 16, 2026, 11:07 AM GMT
Futura Medical Market Cap
Futura Medical has a market cap or net worth of 3.2 million as of June 16, 2026. Its market cap has decreased by -88.91% in one year.
Market Cap
3.20M
Enterprise Value
-204.33K
Revenue
1.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since July 22, 2003, Futura Medical's market cap has decreased from 29.74M to 3.20M, a decrease of -89.25%. That is a compound annual growth rate of -9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.20M | -50.67% |
| Dec 31, 2025 | 6.48M | -93.26% |
| Dec 31, 2024 | 96.12M | 25.06% |
| Dec 29, 2023 | 76.86M | -47.89% |
| Dec 30, 2022 | 147.48M | 30.69% |
| Dec 31, 2021 | 112.85M | 201.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 12.54M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 7.72M |
| OptiBiotix Health | 6.40M |
| CRISM Therapeutics | 5.69M |
| Nuformix | 5.27M |
| Theracryf | 5.16M |
| Thalia Therapeutics | 4.79M |